The present study examined the effects of EGCG on VEGF and MMP-9 protein expression in two colon cancer cell lines: HCT-116 cells, which express wild-type p53, and HT-29 cells, which express mutant p53. The gene discussed is TP53; the disease is malignant colon neoplasm.